F-18 fluorodeoxyglucose positron emission tomography can detect early response to adalimumab, a tumor necrosis factor-α antagonist, in rheumatoid arthritis: A prospective pilot study

Saved in:
Bibliographic Details
Published in:Joint, bone, spine : revue du rhumatisme bone, spine : revue du rhumatisme, 2015-10, Vol.82 (5), p.381-383
Main Authors: Edupuganti, Soujanya Ratna, Eder, Véronique, Ternant, David, Courtehoux, Maxime, Tranquart, François, Goupille, Philippe, Paintaud, Gilles, Mulleman, Denis
Format: Article
Language:English
Subjects:
Adalimumab
Adalimumab - therapeutic use
Adult
Aged
Antirheumatic Agents - therapeutic use
Arthritis, Rheumatoid - diagnostic imaging
Arthritis, Rheumatoid - drug therapy
Female
Fluorodeoxyglucose F18
Follow-Up Studies
Humans
Internal Medicine
Male
Middle Aged
Pilot Projects
Positron emission tomography
Positron-Emission Tomography - methods
Prospective Studies
Radiopharmaceuticals
Rheumatoid arthritis
Rheumatology
Time Factors
Tumor necrosis factor antagonists
Tumor Necrosis Factor-alpha - antagonists & inhibitors
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c417t-51e7adc5d630fe919dd57df2b29f32209702a272f8dbb1c647711f7787ca91fd3
cites cdi_FETCH-LOGICAL-c417t-51e7adc5d630fe919dd57df2b29f32209702a272f8dbb1c647711f7787ca91fd3
container_end_page 383
container_issue 5
container_start_page 381
container_title Joint, bone, spine : revue du rhumatisme
container_volume 82
creator Edupuganti, Soujanya Ratna
Eder, Véronique
Ternant, David
Courtehoux, Maxime
Tranquart, François
Goupille, Philippe
Paintaud, Gilles
Mulleman, Denis
description
doi_str_mv 10.1016/j.jbspin.2015.01.014
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1721350037</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1297319X15000329</els_id><sourcerecordid>1721350037</sourcerecordid><originalsourceid>FETCH-LOGICAL-c417t-51e7adc5d630fe919dd57df2b29f32209702a272f8dbb1c647711f7787ca91fd3</originalsourceid><addsrcrecordid>eNqFUstu1TAQjRCIlsIfIOQli-bicR6-YYFUVZRWqsQCkNhZjj251xfHDrZTkc9ixV_wTTjcwoIN0kgzi3Pmcc4UxXOgG6DQvjpsDn2cjNswCs2GQo76QXEKnG9Lzpr6Ya5Zx8sKus8nxZMYD5TSijXt4-KENZy3dU1Pix9XJWzJYGcfvEb_bdnZWfmIZPLRpOAdwdHEaHKR_Oh3QU77hSjpiMaEKhGUwS4kYJy8y7TkidTSmnEeZX9OJEnz6ANxqEJuGMkgVfKh_PmdSJfkzjsT0zkxjoQ9ZkryRhMZ0j6YZOJrckGmzJvyIHOXdzLWJxLTrJenxaNB2ojP7vNZ8enq7cfL6_L2_buby4vbUtXAU9kAcqlVo9uKDthBp3XD9cB61g0VY7TjlEnG2bDVfQ-qrTkHGLKEXMkOBl2dFS-PffMeX2eMSWQ5FForHfo5CuAMqiYLyzO0PkLXU2PAQUzBjDIsAqhYLRMHcbRMrJYJCjnqTHtxP2HuR9R_SX88yoA3RwDmO-8MBhGVQadQm5CFEdqb_034t4Gyxhkl7RdcMB78HFzWUICITFDxYX2b9Wug-f0xXfULC7XEdA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1721350037</pqid></control><display><type>article</type><title>F-18 fluorodeoxyglucose positron emission tomography can detect early response to adalimumab, a tumor necrosis factor-α antagonist, in rheumatoid arthritis: A prospective pilot study</title><source>ScienceDirect Freedom Collection</source><creator>Edupuganti, Soujanya Ratna ; Eder, Véronique ; Ternant, David ; Courtehoux, Maxime ; Tranquart, François ; Goupille, Philippe ; Paintaud, Gilles ; Mulleman, Denis</creator><creatorcontrib>Edupuganti, Soujanya Ratna ; Eder, Véronique ; Ternant, David ; Courtehoux, Maxime ; Tranquart, François ; Goupille, Philippe ; Paintaud, Gilles ; Mulleman, Denis</creatorcontrib><identifier>ISSN: 1297-319X</identifier><identifier>EISSN: 1778-7254</identifier><identifier>DOI: 10.1016/j.jbspin.2015.01.014</identifier><identifier>PMID: 25776440</identifier><language>eng</language><publisher>France: Elsevier SAS</publisher><subject>Adalimumab ; Adalimumab - therapeutic use ; Adult ; Aged ; Antirheumatic Agents - therapeutic use ; Arthritis, Rheumatoid - diagnostic imaging ; Arthritis, Rheumatoid - drug therapy ; Female ; Fluorodeoxyglucose F18 ; Follow-Up Studies ; Humans ; Internal Medicine ; Male ; Middle Aged ; Pilot Projects ; Positron emission tomography ; Positron-Emission Tomography - methods ; Prospective Studies ; Radiopharmaceuticals ; Rheumatoid arthritis ; Rheumatology ; Time Factors ; Tumor necrosis factor antagonists ; Tumor Necrosis Factor-alpha - antagonists &amp; inhibitors</subject><ispartof>Joint, bone, spine : revue du rhumatisme, 2015-10, Vol.82 (5), p.381-383</ispartof><rights>2015</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c417t-51e7adc5d630fe919dd57df2b29f32209702a272f8dbb1c647711f7787ca91fd3</citedby><cites>FETCH-LOGICAL-c417t-51e7adc5d630fe919dd57df2b29f32209702a272f8dbb1c647711f7787ca91fd3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25776440$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Edupuganti, Soujanya Ratna</creatorcontrib><creatorcontrib>Eder, Véronique</creatorcontrib><creatorcontrib>Ternant, David</creatorcontrib><creatorcontrib>Courtehoux, Maxime</creatorcontrib><creatorcontrib>Tranquart, François</creatorcontrib><creatorcontrib>Goupille, Philippe</creatorcontrib><creatorcontrib>Paintaud, Gilles</creatorcontrib><creatorcontrib>Mulleman, Denis</creatorcontrib><title>F-18 fluorodeoxyglucose positron emission tomography can detect early response to adalimumab, a tumor necrosis factor-α antagonist, in rheumatoid arthritis: A prospective pilot study</title><title>Joint, bone, spine : revue du rhumatisme</title><addtitle>Joint Bone Spine</addtitle><subject>Adalimumab</subject><subject>Adalimumab - therapeutic use</subject><subject>Adult</subject><subject>Aged</subject><subject>Antirheumatic Agents - therapeutic use</subject><subject>Arthritis, Rheumatoid - diagnostic imaging</subject><subject>Arthritis, Rheumatoid - drug therapy</subject><subject>Female</subject><subject>Fluorodeoxyglucose F18</subject><subject>Follow-Up Studies</subject><subject>Humans</subject><subject>Internal Medicine</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Pilot Projects</subject><subject>Positron emission tomography</subject><subject>Positron-Emission Tomography - methods</subject><subject>Prospective Studies</subject><subject>Radiopharmaceuticals</subject><subject>Rheumatoid arthritis</subject><subject>Rheumatology</subject><subject>Time Factors</subject><subject>Tumor necrosis factor antagonists</subject><subject>Tumor Necrosis Factor-alpha - antagonists &amp; inhibitors</subject><issn>1297-319X</issn><issn>1778-7254</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><recordid>eNqFUstu1TAQjRCIlsIfIOQli-bicR6-YYFUVZRWqsQCkNhZjj251xfHDrZTkc9ixV_wTTjcwoIN0kgzi3Pmcc4UxXOgG6DQvjpsDn2cjNswCs2GQo76QXEKnG9Lzpr6Ya5Zx8sKus8nxZMYD5TSijXt4-KENZy3dU1Pix9XJWzJYGcfvEb_bdnZWfmIZPLRpOAdwdHEaHKR_Oh3QU77hSjpiMaEKhGUwS4kYJy8y7TkidTSmnEeZX9OJEnz6ANxqEJuGMkgVfKh_PmdSJfkzjsT0zkxjoQ9ZkryRhMZ0j6YZOJrckGmzJvyIHOXdzLWJxLTrJenxaNB2ojP7vNZ8enq7cfL6_L2_buby4vbUtXAU9kAcqlVo9uKDthBp3XD9cB61g0VY7TjlEnG2bDVfQ-qrTkHGLKEXMkOBl2dFS-PffMeX2eMSWQ5FForHfo5CuAMqiYLyzO0PkLXU2PAQUzBjDIsAqhYLRMHcbRMrJYJCjnqTHtxP2HuR9R_SX88yoA3RwDmO-8MBhGVQadQm5CFEdqb_034t4Gyxhkl7RdcMB78HFzWUICITFDxYX2b9Wug-f0xXfULC7XEdA</recordid><startdate>20151001</startdate><enddate>20151001</enddate><creator>Edupuganti, Soujanya Ratna</creator><creator>Eder, Véronique</creator><creator>Ternant, David</creator><creator>Courtehoux, Maxime</creator><creator>Tranquart, François</creator><creator>Goupille, Philippe</creator><creator>Paintaud, Gilles</creator><creator>Mulleman, Denis</creator><general>Elsevier SAS</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20151001</creationdate><title>F-18 fluorodeoxyglucose positron emission tomography can detect early response to adalimumab, a tumor necrosis factor-α antagonist, in rheumatoid arthritis: A prospective pilot study</title><author>Edupuganti, Soujanya Ratna ; Eder, Véronique ; Ternant, David ; Courtehoux, Maxime ; Tranquart, François ; Goupille, Philippe ; Paintaud, Gilles ; Mulleman, Denis</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c417t-51e7adc5d630fe919dd57df2b29f32209702a272f8dbb1c647711f7787ca91fd3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Adalimumab</topic><topic>Adalimumab - therapeutic use</topic><topic>Adult</topic><topic>Aged</topic><topic>Antirheumatic Agents - therapeutic use</topic><topic>Arthritis, Rheumatoid - diagnostic imaging</topic><topic>Arthritis, Rheumatoid - drug therapy</topic><topic>Female</topic><topic>Fluorodeoxyglucose F18</topic><topic>Follow-Up Studies</topic><topic>Humans</topic><topic>Internal Medicine</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Pilot Projects</topic><topic>Positron emission tomography</topic><topic>Positron-Emission Tomography - methods</topic><topic>Prospective Studies</topic><topic>Radiopharmaceuticals</topic><topic>Rheumatoid arthritis</topic><topic>Rheumatology</topic><topic>Time Factors</topic><topic>Tumor necrosis factor antagonists</topic><topic>Tumor Necrosis Factor-alpha - antagonists &amp; inhibitors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Edupuganti, Soujanya Ratna</creatorcontrib><creatorcontrib>Eder, Véronique</creatorcontrib><creatorcontrib>Ternant, David</creatorcontrib><creatorcontrib>Courtehoux, Maxime</creatorcontrib><creatorcontrib>Tranquart, François</creatorcontrib><creatorcontrib>Goupille, Philippe</creatorcontrib><creatorcontrib>Paintaud, Gilles</creatorcontrib><creatorcontrib>Mulleman, Denis</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Joint, bone, spine : revue du rhumatisme</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Edupuganti, Soujanya Ratna</au><au>Eder, Véronique</au><au>Ternant, David</au><au>Courtehoux, Maxime</au><au>Tranquart, François</au><au>Goupille, Philippe</au><au>Paintaud, Gilles</au><au>Mulleman, Denis</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>F-18 fluorodeoxyglucose positron emission tomography can detect early response to adalimumab, a tumor necrosis factor-α antagonist, in rheumatoid arthritis: A prospective pilot study</atitle><jtitle>Joint, bone, spine : revue du rhumatisme</jtitle><addtitle>Joint Bone Spine</addtitle><date>2015-10-01</date><risdate>2015</risdate><volume>82</volume><issue>5</issue><spage>381</spage><epage>383</epage><pages>381-383</pages><issn>1297-319X</issn><eissn>1778-7254</eissn><cop>France</cop><pub>Elsevier SAS</pub><pmid>25776440</pmid><doi>10.1016/j.jbspin.2015.01.014</doi><tpages>3</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1297-319X
ispartof Joint, bone, spine : revue du rhumatisme, 2015-10, Vol.82 (5), p.381-383
issn 1297-319X
1778-7254
language eng
recordid cdi_proquest_miscellaneous_1721350037
source ScienceDirect Freedom Collection
subjects Adalimumab
Adalimumab - therapeutic use
Adult
Aged
Antirheumatic Agents - therapeutic use
Arthritis, Rheumatoid - diagnostic imaging
Arthritis, Rheumatoid - drug therapy
Female
Fluorodeoxyglucose F18
Follow-Up Studies
Humans
Internal Medicine
Male
Middle Aged
Pilot Projects
Positron emission tomography
Positron-Emission Tomography - methods
Prospective Studies
Radiopharmaceuticals
Rheumatoid arthritis
Rheumatology
Time Factors
Tumor necrosis factor antagonists
Tumor Necrosis Factor-alpha - antagonists & inhibitors
title F-18 fluorodeoxyglucose positron emission tomography can detect early response to adalimumab, a tumor necrosis factor-α antagonist, in rheumatoid arthritis: A prospective pilot study
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-19T00%3A04%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=F-18%20fluorodeoxyglucose%20positron%20emission%20tomography%20can%20detect%20early%20response%20to%20adalimumab,%20a%20tumor%20necrosis%20factor-%CE%B1%20antagonist,%20in%20rheumatoid%20arthritis:%20A%20prospective%20pilot%20study&rft.jtitle=Joint,%20bone,%20spine%20:%20revue%20du%20rhumatisme&rft.au=Edupuganti,%20Soujanya%20Ratna&rft.date=2015-10-01&rft.volume=82&rft.issue=5&rft.spage=381&rft.epage=383&rft.pages=381-383&rft.issn=1297-319X&rft.eissn=1778-7254&rft_id=info:doi/10.1016/j.jbspin.2015.01.014&rft_dat=%3Cproquest_cross%3E1721350037%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c417t-51e7adc5d630fe919dd57df2b29f32209702a272f8dbb1c647711f7787ca91fd3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1721350037&rft_id=info:pmid/25776440&rfr_iscdi=true